150 related articles for article (PubMed ID: 7918493)
1. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.
Bornmann WG; Roepe PD
Biochemistry; 1994 Oct; 33(42):12665-75. PubMed ID: 7918493
[TBL] [Abstract][Full Text] [Related]
2. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport.
Schlemmer SR; Sirotnak FM
J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045
[TBL] [Abstract][Full Text] [Related]
3. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
[TBL] [Abstract][Full Text] [Related]
4. Lysosomotropic agents increase vinblastine efflux from mouse MDR proximal kidney cells exhibiting vectorial drug transport.
Lacave R; Ouar Z; Paulais M; Bens M; Ricci S; Cluzeaud F; Vandewalle A
J Cell Physiol; 1999 Feb; 178(2):247-57. PubMed ID: 10048589
[TBL] [Abstract][Full Text] [Related]
5. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine.
Tseng E; Kamath A; Morris ME
Pharm Res; 2002 Oct; 19(10):1509-15. PubMed ID: 12425469
[TBL] [Abstract][Full Text] [Related]
6. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
[TBL] [Abstract][Full Text] [Related]
7. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
8. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
[TBL] [Abstract][Full Text] [Related]
9. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
Adams DJ; Knick VC
Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
[TBL] [Abstract][Full Text] [Related]
11. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
[TBL] [Abstract][Full Text] [Related]
12. Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.
Shalinsky DR; Heath DD; Jekunen AP; Alcaraz JE; Howell SB
Br J Cancer; 1993 Mar; 67(3):471-9. PubMed ID: 8094975
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
14. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
[TBL] [Abstract][Full Text] [Related]
15. Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate.
Luo L; Xu X; Shi B; Wu J; Hu Y
AAPS J; 2007 Oct; 9(3):E329-35. PubMed ID: 18170979
[TBL] [Abstract][Full Text] [Related]
16. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
17. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Hoffman MM; Wei LY; Roepe PD
J Gen Physiol; 1996 Oct; 108(4):295-313. PubMed ID: 8894978
[TBL] [Abstract][Full Text] [Related]
18. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
Pétriz J; O'Connor JE; Carmona M; García-López J
Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
[TBL] [Abstract][Full Text] [Related]
19. Transfection of mu MDR 1 inhibits Na(+)-independent Cl-/-HCO3 exchange in Chinese hamster ovary cells.
Luz JG; Wei LY; Basu S; Roepe PD
Biochemistry; 1994 Jun; 33(23):7239-49. PubMed ID: 7911682
[TBL] [Abstract][Full Text] [Related]
20. Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: inhibition by taxol and membrane permeabilising agents.
Syed SK; Christopherson RI; Roufogalis BD
Biochem Mol Biol Int; 1993 Jul; 30(4):743-53. PubMed ID: 8104621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
